FDA Revokes EUAs for Six SARS-CoV-2 In Vitro Diagnostic Devices

by | Mar 28, 2024 | CDC LOCS | 1 comment

On March 21, 2024, the U.S. Food and Drug Administration (FDA) published a notice in the Federal Register about the revocation of six Emergency Use Authorizations (EUAs) of in vitro diagnostic devices for detection and/or diagnosis of COVID-19.

Stay Informed!

Stay informed about the latest regulatory announcements, upcoming events, trending accreditation news and other laboratory topics.


Translate »

Pin It on Pinterest

Share This